234P Elinzanetant in breast cancer care: potential drug–drug interaction profile with targeted systemic therapies

ESMO Open 2026 Open access

Read full text
Authors: D.J. Brennan, M. V. Dolezal, A. Rottman, M-H. Schultze-Mosgau, L.A. Wahyudi, F. Cardoso
DOI: 10.1016/j.esmoop.2026.107188
Cited by: 1

Fields of Study & Subjects

HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies PARP inhibition in cancer therapy

Publication details

Journal / source
ESMO Open
Publisher
Elsevier BV
Volume
11
Pages
107188–107188
Publication date
1 May 2026
Language
EN